326 related articles for article (PubMed ID: 26653007)
1. Gradual development of psoriatic skin lesions by constitutive low-level expression of IL-17A.
Wohn C; Brand A; van Ettinger K; Brouwers-Haspels I; Waisman A; Laman JD; Clausen BE
Cell Immunol; 2016 Oct; 308():57-65. PubMed ID: 26653007
[TBL] [Abstract][Full Text] [Related]
2. Antagonization of IL-17A Attenuates Skin Inflammation and Vascular Dysfunction in Mouse Models of Psoriasis.
Schüler R; Brand A; Klebow S; Wild J; Veras FP; Ullmann E; Roohani S; Kolbinger F; Kossmann S; Wohn C; Daiber A; Münzel T; Wenzel P; Waisman A; Clausen BE; Karbach S
J Invest Dermatol; 2019 Mar; 139(3):638-647. PubMed ID: 30367871
[TBL] [Abstract][Full Text] [Related]
3. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease.
Karbach S; Croxford AL; Oelze M; Schüler R; Minwegen D; Wegner J; Koukes L; Yogev N; Nikolaev A; Reißig S; Ullmann A; Knorr M; Waldner M; Neurath MF; Li H; Wu Z; Brochhausen C; Scheller J; Rose-John S; Piotrowski C; Bechmann I; Radsak M; Wild P; Daiber A; von Stebut E; Wenzel P; Waisman A; Münzel T
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2658-68. PubMed ID: 25341795
[TBL] [Abstract][Full Text] [Related]
5. VEGF-A promotes IL-17A-producing γδ T cell accumulation in mouse skin and serves as a chemotactic factor for plasmacytoid dendritic cells.
Suzuki T; Hirakawa S; Shimauchi T; Ito T; Sakabe J; Detmar M; Tokura Y
J Dermatol Sci; 2014 May; 74(2):116-24. PubMed ID: 24485663
[TBL] [Abstract][Full Text] [Related]
6. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
[TBL] [Abstract][Full Text] [Related]
7. Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model.
Nakajima K; Kanda T; Takaishi M; Shiga T; Miyoshi K; Nakajima H; Kamijima R; Tarutani M; Benson JM; Elloso MM; Gutshall LL; Naso MF; Iwakura Y; DiGiovanni J; Sano S
J Immunol; 2011 Apr; 186(7):4481-9. PubMed ID: 21346238
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 17A: toward a new understanding of psoriasis pathogenesis.
Lynde CW; Poulin Y; Vender R; Bourcier M; Khalil S
J Am Acad Dermatol; 2014 Jul; 71(1):141-50. PubMed ID: 24655820
[TBL] [Abstract][Full Text] [Related]
9. Psoriatic inflammation causes hepatic inflammation with concomitant dysregulation in hepatic metabolism via IL-17A/IL-17 receptor signaling in a murine model.
Al-Harbi NO; Nadeem A; Al-Harbi MM; Zoheir KMA; Ansari MA; El-Sherbeeny AM; Alanazi KM; Alotaibi MR; Ahmad SF
Immunobiology; 2017 Feb; 222(2):128-136. PubMed ID: 27773660
[TBL] [Abstract][Full Text] [Related]
10. IL-17A causes depression-like symptoms via NFκB and p38MAPK signaling pathways in mice: Implications for psoriasis associated depression.
Nadeem A; Ahmad SF; Al-Harbi NO; Fardan AS; El-Sherbeeny AM; Ibrahim KE; Attia SM
Cytokine; 2017 Sep; 97():14-24. PubMed ID: 28570931
[TBL] [Abstract][Full Text] [Related]
11. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.
Nadeem A; Al-Harbi NO; Al-Harbi MM; El-Sherbeeny AM; Ahmad SF; Siddiqui N; Ansari MA; Zoheir KM; Attia SM; Al-Hosaini KA; Al-Sharary SD
Pharmacol Res; 2015 Sep; 99():248-57. PubMed ID: 26149470
[TBL] [Abstract][Full Text] [Related]
12. IκBζ: A key protein in the pathogenesis of psoriasis.
Johansen C
Cytokine; 2016 Feb; 78():20-1. PubMed ID: 26615569
[TBL] [Abstract][Full Text] [Related]
13. Role of IL-17A signalling in psoriasis and associated bone loss.
Uluçkan Ö; Wagner EF
Clin Exp Rheumatol; 2016; 34(4 Suppl 98):17-20. PubMed ID: 27586798
[TBL] [Abstract][Full Text] [Related]
14. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
15. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
van der Fits L; Mourits S; Voerman JS; Kant M; Boon L; Laman JD; Cornelissen F; Mus AM; Florencia E; Prens EP; Lubberts E
J Immunol; 2009 May; 182(9):5836-45. PubMed ID: 19380832
[TBL] [Abstract][Full Text] [Related]
16. IL-6 regulates neutrophil microabscess formation in IL-17A-driven psoriasiform lesions.
Croxford AL; Karbach S; Kurschus FC; Wörtge S; Nikolaev A; Yogev N; Klebow S; Schüler R; Reissig S; Piotrowski C; Brylla E; Bechmann I; Scheller J; Rose-John S; Thomas Wunderlich F; Münzel T; von Stebut E; Waisman A
J Invest Dermatol; 2014 Mar; 134(3):728-735. PubMed ID: 24067382
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species produced by myeloid cells in psoriasis as a potential biofactor contributing to the development of vascular inflammation.
Schaller T; Ringen J; Fischer B; Bieler T; Perius K; Knopp T; Kommoss KS; Korn T; Heikenwälder M; Oelze M; Daiber A; Münzel T; Kramer D; Wenzel P; Wild J; Karbach S; Waisman A
Biofactors; 2023; 49(4):861-874. PubMed ID: 37139784
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.
Couderc E; Morel F; Levillain P; Buffière-Morgado A; Camus M; Paquier C; Bodet C; Jégou JF; Pohin M; Favot L; Garcia M; Huguier V; Mcheik J; Lacombe C; Yssel H; Guillet G; Bernard FX; Lecron JC
PLoS One; 2017; 12(7):e0181486. PubMed ID: 28708859
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-17A Drives IL-19 and IL-24 Expression in Skin Stromal Cells Regulating Keratinocyte Proliferation.
Xu X; Prens E; Florencia E; Leenen P; Boon L; Asmawidjaja P; Mus AM; Lubberts E
Front Immunol; 2021; 12():719562. PubMed ID: 34616394
[TBL] [Abstract][Full Text] [Related]
20. Galectin-7 downregulation in lesional keratinocytes contributes to enhanced IL-17A signaling and skin pathology in psoriasis.
Chen HL; Lo CH; Huang CC; Lu MP; Hu PY; Chen CS; Chueh DY; Chen P; Lin TN; Lo YH; Hsiao YP; Hsu DK; Liu FT
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33055419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
